Boston Scientific elects former Lixil CEO to its board of directors

Tim Casey | | Cardiovascular Business | Patient Care

Yoshiaki Fujimori, a former Lixil Group Corporation CEO and General Electric executive, was elected to Boston Scientific’s board of directors on July 12.

Lixil announced in December 2015 that Fujimori would step down as CEO of the Tokyo-based company on Jan. 1, 2016. Lixil is a housing-related holding company that manufactures and sells building materials and housing equipment, operates home centers and offers real estate services.

Fujimori said his resignation from Lixil was “totally unrelated” to an accounting scandal at a Lixil subsidiary operating in China, according to the Wall Street Journal.

Fujimori joined Lixil after spending 25 years with General Electric, where he served as chairman, president and CEO of GE Japan for more than three years.

Fujimori is also an external director of Tokyo Electric Power Company and Takeda Pharmaceutical Company Limited.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."